Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 269 entries
View as:

Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe

Phase: N/A Priority: Normal
NCT ID: NCT05405985 Org: User:
Start: 08/11/22 End: 12/08/22 Due: 12/08/23

Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01209949 Org: User:
Start: 10/31/10 End: 01/31/11 Due: 01/31/12

Patient-Reported Outcome Of Facial Erythema (PROOF)

Phase: N/A Priority: Normal
NCT ID: NCT01885000 Org: User:
Start: 07/01/13 End: 11/14/13 Due: 11/14/14

Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin

Phase: N/A Priority: Normal
NCT ID: NCT01046565 Org: User:
Start: 01/31/10 End: 02/28/10 Due: 02/28/11

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT03960957 Org: User:
Start: 06/17/19 End: 04/16/20 Due: 04/16/21

An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%

Phase: N/A Priority: Normal
NCT ID: NCT00668655 Org: User:
Start: 02/29/08 End: 03/31/08 Due: 03/31/09

Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application

Phase: N/A Priority: Normal
NCT ID: NCT00436527 Org: User:
Start: 08/31/06 End: 08/31/06 Due: 08/31/07

Comparison of Mechanical Penetration Enhancers on Metvixia Skin Penetration

Phase: N/A Priority: Normal
NCT ID: NCT02511145 Org: User:
Start: 02/28/14 End: 05/31/14 Due: 05/31/15

Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%

Phase: N/A Priority: Normal
NCT ID: NCT00660985 Org: User:
Start: 05/31/08 End: 11/30/08 Due: 11/30/09

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

Phase: N/A Priority: Normal
NCT ID: NCT03292406 Org: User:
Start: 12/19/17 End: 03/17/20 Due: 03/17/21

A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV)

Phase: N/A Priority: Normal
NCT ID: NCT04451330 Org: User:
Start: 07/29/20 End: 04/26/21 Due: 04/26/22

Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies

Phase: N/A Priority: Normal
NCT ID: NCT06351358 Org: User:
Start: 02/19/24 End: 05/31/25 Due: 05/31/26

Treatment of Pectus Excavatum Deformity Using Macrolane Filler

Phase: N/A Priority: Normal
NCT ID: NCT01750112 Org: User:
Start: 12/31/12 End: 09/30/16 Due: 09/30/17

Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%

Phase: N/A Priority: Normal
NCT ID: NCT00437151 Org: User:
Start: 06/30/06 End: 06/30/07 Due: 06/30/08

Emervel for the Correction of Lower Face Wrinkles & Folds

Phase: N/A Priority: Normal
NCT ID: NCT02718040 Org: User:
Start: 04/30/16 End: 08/31/16 Due: 08/31/17

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00437255 Org: User:
Start: 08/31/06 End: 06/30/07 Due: 06/30/08

A Study to Evaluate Efficacy and Safety of Macrolane VRF30 for Volume Restoration and Contouring of the Buttocks

Phase: N/A Priority: Normal
NCT ID: NCT01331408 Org: User:
Start: 09/30/08 End: 05/31/11 Due: 05/31/12

Restylane Defyne in a Stepwise Treatment Approach

Phase: N/A Priority: Normal
NCT ID: NCT04520997 Org: User:
Start: 12/07/20 End: 09/15/21 Due: 09/15/22

A Study to Evaluate Effectiveness and Safety of Hyaluronic Acid (HA) Fillers

Phase: N/A Priority: Normal
NCT ID: NCT03869450 Org: User:
Start: 11/09/18 End: 08/30/19 Due: 08/30/20

Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma

Phase: N/A Priority: Normal
NCT ID: NCT00472966 Org: User:
Start: 11/30/06 End: 04/30/07 Due: 04/30/08

Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne

Phase: N/A Priority: Normal
NCT ID: NCT01106807 Org: User:
Start: 04/30/10 End: 09/30/10 Due: 09/30/11

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT04921345 Org: User:
Start: 06/24/21 End: 07/31/25 Due: 07/31/26

Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

Phase: N/A Priority: Normal
NCT ID: NCT01318733 Org: User:
Start: 03/31/11 End: 07/31/12 Due: 07/31/13

A Study of Treatment Preference During Cheek Contouring Comparing Restylane® SubQ With and Without the Addition of Lidocaine Hydrochloride

Phase: N/A Priority: Normal
NCT ID: NCT01431755 Org: User:
Start: 09/30/11 End: 10/31/12 Due: 10/31/13

Treatment of Moderate to Severe Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT04249583 Org: User:
Start: 02/10/20 End: 01/05/21 Due: 01/05/22